Suppressing CDK7 and CDK9 activity has been known to substantially reduce MYC expression and downregulate MYC target genes in T cell acute lymphoblastic leukaemia, mixed-lineage leukaemia, neuroblastomas and small-cell lung cancers [77,78]. The gene discussed is MYC; the disease is small cell lung carcinoma.